Miguel Torralba-González

25PUBLICATIONS
119CO-AUTHORS
Innate immunityTraditional, complementary and integrative medicine not elsewhere classifiedPacific Peoples life coursePredictive and prognostic markersMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Oct 23, 2026
Long-term Effectiveness, Treatment Persistence, and Timing of Virological Failure With Long-Acting Cabotegravir Plus Rilpivirine in Real-World HIV Care: RELATIVITY Cohort.

|Sep 17, 2026
Quality of life among older adults with HIV after switching to bictegravir-based three-drug or dolutegravir-based two-drug regimens.

|Aug 18, 2026
Patient-Reported Outcomes with Long-Acting Cabotegravir and Rilpivirine in People Living with HIV.

|Jul 25, 2026
Cumulative Metformin Use and Hepatocellular Carcinoma Risk After HCV SVR: A Multicentre Cohort Study.

|Jul 16, 2026
Effect of Non-nucleoside Resistance-Associated Mutations on the Effectiveness of Long-Acting Cabotegravir + Rilpivirine Therapy: Insights From the Real-World RELATIVITY Cohort.

|Apr 21, 2026
Effectiveness and Persistence of Long-Acting Injectable Cabotegravir and Rilpivirine in Migrant Individuals Living With HIV in Spain: Substudy of the RELATIVITY Cohort.

Pageof 5

Frequent Collaborators

5 joint publications

Alfonso Cabello-Úbeda

5 joint publications

Jesús Troya García

5 joint publications

Pablo Martínez-Blanco

4 joint publications

Juan Tiraboschi